Nicholas R. Hoeh

85 Park Road
Grafton, AUK 1023, New Zealand

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Effectiveness of written exposure therapy for reducing depressive symptoms in individuals with posttraumatic stress disorder: A systematic review.

Effectiveness of written exposure therapy for reducing depressive symptoms in individuals with posttraumatic stress disorder: A systematic review.

Journal: Journal of traumatic stress
Published: August 05, 2026

Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm study.

Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm study.

Journal: Frontiers in pharmacology
Published: December 14, 2025

LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.

LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.

Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: October 02, 2025

Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context.

Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context.

Journal: Journal of psychoactive drugs
Published: July 03, 2025

Scopolamine's Anticholinergic Effects on EEG Spectral, Aperiodic, Complexity, Microstates, and Heart Rate Variability.

Scopolamine's Anticholinergic Effects on EEG Spectral, Aperiodic, Complexity, Microstates, and Heart Rate Variability.

Journal: Human psychopharmacology
Published: June 03, 2025

What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial.

What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial.

Journal: Therapeutic advances in psychopharmacology
Published: April 02, 2025

Practitioners' attitudes and approaches to assessing comorbid depression among patients seeking assisted dying in New Zealand.

Practitioners' attitudes and approaches to assessing comorbid depression among patients seeking assisted dying in New Zealand.

Journal: Psychiatry, psychology, and law : an interdisciplinary journal of the Australian and New Zealand Association of Psychiatry, Psychology and Law
Published: March 17, 2025

Mapping Neuroinflammation With Diffusion-Weighted Magnetic Resonance Imaging: A Randomized Crossover Study.

Mapping Neuroinflammation With Diffusion-Weighted Magnetic Resonance Imaging: A Randomized Crossover Study.

Journal: Biological psychiatry. Cognitive neuroscience and neuroimaging
Published: February 03, 2025

The first year of assisted dying in New Zealand through the lens of healthcare professionals not directly involved in the process.

The first year of assisted dying in New Zealand through the lens of healthcare professionals not directly involved in the process.

Journal: BMC palliative care
Published: January 28, 2025

Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.

Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.

Journal: Neuropharmacology
Published: November 28, 2024

LSD microdosing in major depressive disorder: results from an open-label trial.

LSD microdosing in major depressive disorder: results from an open-label trial.

Journal: Neuropharmacology
Published: November 18, 2024

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

Journal: Trials
Published: April 18, 2024
Showing 1-12 of 37

Last Updated: 09/26/2026